| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/28/2002 | WO2002015885A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2002015878A1 Aqueous suspension preparations |
| 02/28/2002 | WO2002015871A1 Use of tyramine in cosmetic compositions to lighten the skin |
| 02/28/2002 | WO2002015870A2 Substances for inducing and intensifying the tanning mechanisms of the skin |
| 02/28/2002 | WO2002015868A2 Cosmetic formulation containing at least one di-sugar alcohol phosphate of c3 to c6 sugar alcohols |
| 02/28/2002 | WO2002015867A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations |
| 02/28/2002 | WO2002015866A2 Use of cyclic 2,4-diphosphoglycerates (cdgp) and/or derivatives thereof in cosmetic and dermatological formulations |
| 02/28/2002 | WO2002015863A1 Dermatological composition |
| 02/28/2002 | WO2002015851A2 Storage stable tretinoin and 4-hydroxy anisole containing topical composition |
| 02/28/2002 | WO2002015846A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/28/2002 | WO2002000269A8 The use of honey in wound dressings |
| 02/28/2002 | WO2001087236A3 Topical administration of pharmacological compositions for non-systemic treatment of pruritus |
| 02/28/2002 | WO2001087234A3 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079216A3 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 02/28/2002 | WO2001076530A3 Il-8 receptor antagonists |
| 02/28/2002 | WO2001072970A3 Methods to prepare and use epidermal stem cells |
| 02/28/2002 | WO2001072281A3 Microspheres for active embolization |
| 02/28/2002 | WO2001070255A3 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 02/28/2002 | WO2001068654A3 Tubulin binding ligands and corresponding prodrug constructs |
| 02/28/2002 | WO2001064639A3 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 02/28/2002 | WO2001049309A3 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 02/28/2002 | WO2001045661A3 Cosmetic and/or pharmaceutical preparations |
| 02/28/2002 | WO2001043755A3 Regenerative adjuvant (3-way tap) |
| 02/28/2002 | WO2001043701A3 Cosmetic or dermopharmaceutical compositions containing the n-palmytoyl-gly-hys-lys tripeptide |
| 02/28/2002 | WO2001042216A3 Caspase inhibitors and uses thereof |
| 02/28/2002 | WO2001041776B1 Use of honey in medical dressings |
| 02/28/2002 | WO2001040444A3 Method and compositions for producing cell transplants |
| 02/28/2002 | WO2001031029A3 Human sphingosine kinase gene |
| 02/28/2002 | WO2001027254A3 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 02/28/2002 | WO2001024804A3 Method for preparing a composition by mother-of-pearl extraction, and use thereof in cosmetics and dermatology |
| 02/28/2002 | WO2001005422A3 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 02/28/2002 | WO2001001970A3 New uses potassium channel openers, such as the treatment of epilepsy |
| 02/28/2002 | WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/28/2002 | US20020026060 RAR selective retinoid agonists |
| 02/28/2002 | US20020026056 Substituted imidazoles having cytokine inhibitory activity |
| 02/28/2002 | US20020025966 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 02/28/2002 | US20020025936 Motilide compounds |
| 02/28/2002 | US20020025558 Human MAD proteins and uses thereof |
| 02/28/2002 | US20020025345 Administering manganese and/or its salt for for relaxing and/or slackening cutaneous and/ or subcutaneous vascular tissue and combating skin pallor |
| 02/28/2002 | US20020025301 Novel flavonoids and their use in cosmetic and dermatological preparations |
| 02/28/2002 | CA2421062A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | CA2420190A1 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2420179A1 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | CA2420024A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | CA2419872A1 Identification of a human n-terminal acetyltransferase gene |
| 02/28/2002 | CA2419840A1 Treatment of hyperproliferative diseases |
| 02/28/2002 | CA2419580A1 Integrin receptor inhibitors |
| 02/28/2002 | CA2419274A1 Methods and compositions for treating ige-related disease using nnt-1 inhibitors |
| 02/28/2002 | CA2418730A1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | CA2415791A1 Treatment of wounds |
| 02/28/2002 | CA2411924A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting proteinkinases |
| 02/27/2002 | EP1181927A1 Agents improving skin barrier function |
| 02/27/2002 | EP1181390A1 27 human secreted proteins |
| 02/27/2002 | EP1181385A2 Modulation of gene expression in gastrointestinal inflammation |
| 02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 02/27/2002 | EP1181364A1 Lipid metabolism transcription factor |
| 02/27/2002 | EP1181354A1 Method for multiplying stem cells |
| 02/27/2002 | EP1181329A1 Silicone gel containing salicylic acid |
| 02/27/2002 | EP1181316A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
| 02/27/2002 | EP1181310A1 Chemokine receptor ccr3 antagonists |
| 02/27/2002 | EP1181305A1 Methods of modulating activity of prokaryotic ribosomes |
| 02/27/2002 | EP1181303A1 50 human secreted proteins |
| 02/27/2002 | EP1181288A1 Bicyclic oxazolidinones as antibacterial agent |
| 02/27/2002 | EP1181286A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 02/27/2002 | EP1181285A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 02/27/2002 | EP1181282A2 Benzothiazinone and benzoxazinone compounds |
| 02/27/2002 | EP1181278A1 Cyclic amine derivatives and their uses |
| 02/27/2002 | EP1181276A1 Morpholino-n-ethyl ester derivative of an indole spla-2 inhibitor |
| 02/27/2002 | EP1181054A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders |
| 02/27/2002 | EP1181053A2 Use of soluble costimulatory molecules to enhance immune responses |
| 02/27/2002 | EP1181051A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF IMMUNOLOGICALLY-MEDIATED DISEASES USING i MYCOBACTERIUM VACCAE /i |
| 02/27/2002 | EP1181047A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 02/27/2002 | EP1181031A1 Novel antiangiogenic peptides |
| 02/27/2002 | EP1181029A1 Balsam for the treatment of surface burns and chafing rashes |
| 02/27/2002 | EP1181022A1 Medicinal compositions and their method of preparation |
| 02/27/2002 | EP1181019A1 Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome |
| 02/27/2002 | EP1181006A1 Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions |
| 02/27/2002 | EP1181001A2 Sunscreen composition containing sol-gel microcapsules |
| 02/27/2002 | EP1003559B1 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/27/2002 | EP0892789B1 Irreversible inhibitors of tyrosine kinases |
| 02/27/2002 | CN1337961A Heteroaryl amidines, methyl amidiues and guanidines as protease inhibitors |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337952A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 02/27/2002 | CN1337949A Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid as TACE inhibitor |
| 02/27/2002 | CN1337944A Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid as TACE inhibitors |
| 02/27/2002 | CN1337931A Retinoid antagonists and use thereof |
| 02/27/2002 | CN1337882A Pharmaceutical composition for the treatment o f rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 02/27/2002 | CN1337269A Local therapeutic method for skin |
| 02/27/2002 | CN1337267A Chinese medicine decoction for eliminating purplish and white patches on the skin |
| 02/27/2002 | CN1337266A Leukoderma liniment |
| 02/27/2002 | CN1337250A Compound Wuduqing capsule of blister beetle |
| 02/27/2002 | CN1337234A Compound alum powder and its prepn |
| 02/27/2002 | CN1337226A Calamine lotion |
| 02/27/2002 | CN1079792C 酶抑制剂 Inhibitors |